Duration of rocuronium-induced neuromuscular block under total intravenous aneshtesia in pediatric patient

Duration of rocuronium-induced neuromuscular block under total intravenous aneshtesia in pediatric patient - Duration of rocuronium-induced neuromuscular block under total intravenous aneshtesia in pediatric patient

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012992

Enrollment

Registered

2014-01-28

Start date

2014-01-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical pediatric patients requiring general anesthesia

Interventions

The patients will recive sugammadex 2mg/kg when train of four(TOF) 2/4.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients aged 12 years old and below 2) ASA risk classification 1 and 2 3) Patients consented to participate in this study

Exclusion criteria

Exclusion criteria: 1)Patients having allergic factors to neuromuscular blocking agents

Design outcomes

Primary

Measure	Time frame
Recovery time of T1 to 10% after single administration of rocuronium	—

Countries

Japan

Contacts

Public ContactSekijima Chihiro

Saitama Children's medical center Department of anesthesiology

sekijima.chihiro@pref.saitama.lg.jp+81-48-758-1811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026